Calcifediol (25-OH-D3)

Calcifediol (25-hydroxyvitamin D3) is the primary storage form and biomarker of vitamin D status in the body. It converts to the active hormone calcitriol in target tissues, regulating calcium absorption, immune function, and bone health through vitamin D receptor activation.

Origin & History

Calcifediol, also known as 25-hydroxyvitamin D3, is a prehormone produced in the liver by hydroxylation of vitamin D3. It is an important indicator of vitamin D status in the body.

Historical & Cultural Context

Calcifediol has been used in clinical settings to monitor and manage vitamin D-related health issues, reflecting its importance in modern medicine.

Health Benefits

- Enhances calcium absorption, supporting bone density and reducing fracture risk by up to 33%. This is crucial for maintaining strong bones as you age. - Boosts immune function by modulating T-cell responses, helping your body fend off infections more effectively. - Improves muscle function and reduces fall risk in older adults by enhancing muscle strength. This is vital for maintaining mobility and independence. - Supports cardiovascular health by reducing arterial stiffness, which can lower blood pressure by up to 10%. - Promotes mood stability by influencing serotonin levels, potentially reducing symptoms of depression. - Aids in glucose metabolism, which can help in managing blood sugar levels and reducing diabetes risk. - Supports brain health by reducing inflammation and oxidative stress, which are linked to cognitive decline.

How It Works

Calcifediol is converted to calcitriol (1,25-dihydroxyvitamin D3) by the enzyme 1α-hydroxylase in kidneys and peripheral tissues. Calcitriol binds to vitamin D receptors (VDR), forming complexes with retinoid X receptors that regulate gene transcription. This activates calcium-binding proteins like calbindin and modulates immune cell differentiation through cytokine production.

Scientific Research

Research on Calcifediol includes randomized controlled trials (RCTs) demonstrating its efficacy in improving vitamin D status. Meta-analyses support its role in bone health and immune function.

Clinical Summary

Clinical trials demonstrate calcifediol supplementation increases 25(OH)D levels 2.5-3 times more efficiently than cholecalciferol. A meta-analysis of 8 studies (n=30,716) showed vitamin D supplementation reduced fracture risk by 19-33%. Immune function studies indicate 25(OH)D levels above 30 ng/mL correlate with reduced respiratory infection rates. However, most bone health studies used cholecalciferol rather than calcifediol specifically.

Nutritional Profile

Calcifediol (25-hydroxyvitamin D3) is a pre-hormone and the primary circulating metabolite of vitamin D3 (cholecalciferol), not a traditional macronutrient or food-based micronutrient. It is the hepatic hydroxylation product of vitamin D3, formed in the liver via CYP2R1 and CYP27A1 enzymes. Molecular weight: 400.64 g/mol. As a supplement, it is available in soft-gel capsule form, commonly dosed at 10–60 mcg (400–2,400 IU equivalent in vitamin D3 activity terms), though calcifediol has approximately 3.2x greater potency per microgram than cholecalciferol in raising serum 25(OH)D levels. Serum target reference range: 30–60 ng/mL (75–150 nmol/L). Bioavailability is significantly superior to cholecalciferol, particularly in individuals with fat malabsorption syndromes (e.g., Crohn's disease, bariatric surgery patients), as calcifediol is more water-soluble and does not require lymphatic chylomicron transport to the same degree. Half-life in circulation: approximately 15–25 days, considerably longer than the parent compound D3 (~24 hours). It contains no macronutrients (zero protein, fat, or carbohydrates in active form), no dietary fiber, and no caloric value. Key bioactive role: serves as the immediate substrate for renal CYP27B1 enzyme conversion to calcitriol (1,25-dihydroxyvitamin D3), the biologically active hormonal form. Cofactors required for optimal metabolism include magnesium (for enzyme activation), vitamin K2 (for downstream calcium utilization), and zinc. No significant mineral or secondary micronutrient content inherent to the compound itself.

Preparation & Dosage

Typical dosages of Calcifediol vary based on individual needs and medical advice. Consult a healthcare provider before use.

Synergy & Pairings

Vitamin K2, Magnesium, Calcium

Safety & Interactions

Calcifediol is generally well-tolerated at doses up to 20 mcg daily, though hypercalcemia risk increases above this threshold. It may enhance absorption of thiazide diuretics and digitalis glycosides, requiring monitoring. Contraindicated in hypercalcemia, kidney stones, and sarcoidosis. Pregnancy safety data is limited, though vitamin D deficiency poses greater risks than moderate supplementation during pregnancy.